GlassScriptPhysician profile
Vincent A Sawma
NPI 1205036589
$441.89
in general payments reported to CMS, 2019-2025
8 companies · $63.71 in 2025
The $63.71 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2022: $30.02 · 2023: $132 · 2024: $78.68 · 2025: $63.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $274.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $137.53 | 2019 | |
| Philips North America LLC | $85.20 | 2024-2025 | (Ck7) Extended Holter, Extended Holter |
| Channel Medsystems, INC. | $58.23 | 2023 | |
| Astellas Pharma US INC | $43.92 | 2022-2023 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.89 | 2025 | Xifaxan |
| Acella Pharmaceuticals, LLC | $32.39 | 2023-2024 | NP Thyroid 60 |
| Pfizer INC. | $26.45 | 2023 | |
| Medline Industries LP | $14.28 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Sawma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.